Target: BRAF V600

Ivette Giancola tells CBS News that when she learned she had stage four pancreatic cancer, she wasn't sure she was going to make it.

"You hear the word 'metastasized' and it's very, very scary," she says.

However, CBS News says that Giancola was eligible to take part in a personalized medicine study using a therapeutic targeted to a genetic mutation found in her tumor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.